An Effectiveness and Safety Study of CONCERTA® (Methylphenidate Hydrochloride) in the Treatment of Adolescents With Attention Deficit Hyperactivity Disorder
Clinical trial NCT00249353 · COMPLETED
Trial details
- NCT number
- NCT00249353
- Sponsor
- McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-03-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.